Of three recent studies that examined the influence of TS polymorphism on chemotherapy toxicity, one revealed no significant abnormality and the others indicated that TS 2R and 3R allele polymorphisms were significantly associated with lower frequencies of leukocytopenia, thrombocytopenia, and peripheral neuropathy [6,23,29]. Here, TYMS is linked to Thrombocytopenia.